Deep search
Profile Picture
  • All
  • Search
  • Copilot
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Past 24 hours
    • Any time
    • Past hour
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

The Lancet1h
Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial
Copyright: © 2025 The Author(s). Published by Elsevier Ltd.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now

DOJ reaches deal w/ Boeing
8 found guilty in robbery
Diagnosed w/ brain disorder
Caught up in Trump's fight
Jones' husband dies
Super vision contact lenses?
Agrees to plead guilty
Allows to shield DOGE docs
Convicted of manslaughter
Signs nuclear energy orders
Signs bill to protect parks
Judge halts Trump admin
Delta stowaway found guilty
Trump threatens 25% tariff
Drops Swift subpoena
TN executes Oscar Smith
Signs $45M+ rookie contract
Inmate escapes for 2nd time
Violated civil rights law?
Probes Media Matters
Redbird to buy Telegraph
US indicts Russian man
South Africa mine rescue
'Avengers' movies delayed
Reveals All-Defensive teams
RU-UKR begin prisoner swap
Record floodwaters in AU
Hamburg stabbing
FTC withdraws lawsuit
Leaves game with injury
Sues 4 New Jersey cities
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy